Skip To Main Content
Hamda A Ali on Muck Rack

Hamda A Ali

As seen in: Diabetes Research and Clinical Practice
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hamda A

Contact Hamda A, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Corrigendum to “Automated insulin delivery for safe fasting and exercise during Ramadan in patients with type 1 diabetes: The active fast study”. [DIAB 226 (2025) 112353]

|
By Khaled Baagar, Hamda A Ali, Fateen Ata, Kawsar Mohamud
| Diabetes Research and Clinical Practice Verified
The authors regret to inform that the following information was missing in the published article. The use of the “Diabetes Treatment Satisfaction Questionnaire - DTSQ” was licensed as mentioned in the publication on page 3 under section (8. Patient-Reported Outcomes): “We were granted a license from Health Psychology Research LTD (Ref: CB1300), on 13 December 2022, to use the DTSQ”.
Open in Who Shared Issue with article?

Automated insulin delivery for safe fasting and exercise during Ramadan in patients with type 1 diabetes: The active fast study

|
By Khaled Baagar, Hamda A Ali, Fateen Ata, Kawsar Mohamud
| Diabetes Research and Clinical Practice Verified
Keywords Type 1 Diabetes Advanced Hybrid Closed-Loop System Ramadan Fasting MiniMed™ 780G Exercise 1 Introduction The increasing role of automated insulin delivery systems (AIDs), such as the MiniMed™ 780G has significantly improved the outcomes of type 1 diabetes mellitus (T1DM) by reducing HbA1c and time above range (TAR) while increasing time in range (TIR) and significantly enhancing the quality of life among the patients living with T1DM [1–3].
Open in Who Shared Issue with article?

Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study)

|
By Tarik Elhadd, Mohamed EL Bashir, Khaled A Baager, Hamda A Ali
| Diabetes Research and Clinical Practice Verified
Abstract Background and Hypothesis Patients with type-2 diabetes mellitus (T2DM) on multiple glucose-lowering therapies who fast during Ramadan are at increased risk of hypoglycemia. We have assessed the utility of the flash glucose monitoring system after adjusting the dose of insulin and sulphonylureas to mitigate the risk of hypoglycemia in patients with T2DM who fast during Ramadan.
Open in Who Shared Issue with article?
See all 3 articles